| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.8 |